Taisho Of Japan To Buy BMS Indonesia Arm, Asia OTC Line
This article was originally published in PharmAsia News
Executive Summary
Japan's Taisho Pharmaceutical plans to buy an Indonesia subsidiary of U.S.-based Bristol-Myers Squibb and its branded over-the-counter drugs